Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches
Author:
Affiliation:
1. Department of Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
2. Academy of Medical Science, Henan Medical College of Zhengzhou University, Zhengzhou, Henan 450052, China
Abstract
Funder
National Natural Science Foundation of China
China Postdoctoral Science Foundation
Publisher
Royal Society of Chemistry (RSC)
Subject
Genetics,Molecular Biology,Biochemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2023/MO/D2MO00220E
Reference102 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2. Tumour heterogeneity and resistance to cancer therapies
3. Involvement of partial EMT in cancer progression
4. The resurgence of platinum-based cancer chemotherapy
5. Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MEF2A, a gene associated with mitochondrial biogenesis, promotes drug resistance in gastric cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2025-01
2. Advancements in platinum-based anticancer drug development: A comprehensive review of strategies, discoveries, and future perspectives;Bioorganic & Medicinal Chemistry;2024-10
3. FOXA2 Activates RND1 to Regulate Arachidonic Acid Metabolism Pathway and Suppress Cisplatin Resistance in Lung Squamous Cell Carcinoma;The Clinical Respiratory Journal;2024-08
4. A novel Pt2+ complex containing 1,4-benzodioxan-6-amine: Stability, DNA binding, and antitumor effects against human breast cancer cells;Chemistry of Inorganic Materials;2024-08
5. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on drug response genes to predict prognosis and therapeutic response in ovarian cancer;Heliyon;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3